Air Pollution Raises MS Risk and Triggers Relapses

Credibility

Interest

Key Takeaway

Both long-term and short-term exposure to common air pollutants are linked to a higher chance of getting MS and to more active or worsening disease for people who already have MS.

What They Found

Researchers combined 22 studies with over 16 million people to see if air pollution affects MS. They found that long-term exposure to fine particles (PM2.5 and PM10) and carbon monoxide (CO) was linked to a higher chance of developing MS — think of long-term exposure like living near a busy road for years. Short-term spikes in pollution (days to weeks) from tiny particles (PM2.5 and PM10), nitrogen dioxide (NO2), and ozone were linked to more MS relapses — like a flare-up after a few bad-air days. Short-term higher PM2.5 and PM10 were also tied to more contrast-enhancing brain lesions on MRI, which are signs of active inflammation. PM10 was additionally linked to faster disability worsening, measured by a common MS disability scale.

Who Should Care and Why

People with MS and their caregivers should care because pollution may make relapses and brain inflammation more likely — similar to how skipping sleep or getting sick can trigger a flare. Those at risk for MS (family history or other risk factors) may want to consider air quality when choosing where to live, just like avoiding known triggers such as smoking. Care teams and neurologists may use this information when advising patients about minimizing exposure on high-pollution days. Caregivers can help by reducing indoor pollution (for example, using air purifiers or keeping windows closed during smoky or smoggy days) and planning outdoor activities when air quality is better. Public health advocates and communities can use these findings to push for cleaner air policies, which could protect many people’s brain health, including those with MS.

Important Considerations

These results come from observational studies, which can show links but cannot prove pollution directly causes MS or relapses — other factors might play a role. The studies combined different designs, locations, and ways of measuring pollution, so the exact size of the risk may vary by place and person. Also, some pollutant links (like the big effect seen for CO) came from fewer studies and have wide uncertainty, so we should be cautious in interpreting that specific number.

Categories:

MS Progression Early Research MS Genetics

Article Topics:

air pollutiondisabilitymultiple sclerosisneurodegenerationrelapses

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of clinical and translational neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News